Whether which of AR-activated growth factors may affect BPH development may be ambiguous, however, there were some previous evidences that decreased expressions of VEGF, TGF-ß1 [30, 31], and IGF1 [32, 33] were associated with inhibition of hyperplastic growth of prostate [29]. Here, VEGFA is linked to benign prostatic hyperplasia.